Synageva BioPharma To Host 2014 Fourth Quarter And Full Year Financial Results Conference Call On February 26

LEXINGTON, Mass., Feb. 19, 2015 /PRNewswire/ -- Synageva BioPharma Corp. (Synageva) GEVA, a biopharmaceutical company developing therapeutic products for rare diseases, will report 2014 fourth quarter and full year financial results after the NASDAQ Market closes on Thursday, February 26, 2015.  Synageva management will conduct a conference call and audio webcast to discuss these results as well as provide a general business update at 4:30 p.m. EST on the same day. 

Dial-in number for the conference call:
U.S. (877) 445-4603
International (443) 295-9270

A live webcast of the call will be available from the "Events & Presentations" section of the Investor Relations tab on the home page of Synageva's website at www.synageva.com. 

Synageva routinely posts information that may be important to investors in the "Investor Relations" section of the company's website at www.synageva.com.  Synageva encourages investors and potential investors to consult this website regularly for important information about the company.

Further information regarding Synageva is available at www.synageva.com.

"Synageva BioPharma™" is a trademark, and "Dedicated to Rare Diseases®" is a registered trademark, of Synageva BioPharma Corp. 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/synageva-biopharma-to-host-2014-fourth-quarter-and-full-year-financial-results-conference-call-on-february-26-300038140.html

SOURCE Synageva BioPharma Corp.